Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haner Direskeneli

Showing results (241-250 of 327) with videos related to

Pageof 33
Sort By:
International Journal of Rheumatic Diseases|May 23, 2022
Metabolic syndrome is associated with increased cardiovascular risk and disease damage in patients with Takayasu arteritisBurçin Sağlam, Sema Kaymaz-Tahra, Gökçe Kenar, et al.
BMC Medical Genomics|May 4, 2019
Structural variation of centromeric endogenous retroviruses in human populations and their impact on cutaneous T-cell lymphoma, Sézary syndrome, and HIV infectionMark H Kaplan, Mark Kaminski, Judith M Estes, et al.
Rheumatology (Oxford, England)|July 21, 2021
The assessment of presenteeism and activity impairment in Behçet's syndrome and recurrent aphthous stomatitis: a multicentre studyUmit Karacayli, Adebowale Adesanya, Aysun Aksoy, et al.
Infectious Diseases & Clinical Microbiology|April 18, 2024
Factors Associated with 28-day Critical Illness Development During the First Wave of COVID-19Uluhan Sili, Pınar Ay, Hüseyin Bilgin, et al.
Annals of the Rheumatic Diseases|January 24, 2018
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practiceChristian Dejaco, Sofia Ramiro, Christina Duftner, et al.
Seminars in Arthritis and Rheumatism|October 27, 2021
Biologic treatments in Takayasu's Arteritis: A comparative study of tumor necrosis factor inhibitors and tocilizumabFatma Alibaz-Oner, Sema Kaymaz-Tahra, Özün Bayındır, et al.
International Journal of Rheumatic Diseases|June 8, 2026
Outcomes of Vascular Interventions in Takayasu Arteritis and the Role of Biologic Therapy: A Multicenter Retrospective StudyAysegul Avcu, Sema Kaymaz-Tahra, Rıza Can Kardas, et al.
Arthritis and Rheumatism|December 14, 2004
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis TrialFrédéric A Houssiau, Carlos Vasconcelos, David D'Cruz, et al.
The Lancet. Rheumatology|November 22, 2025
Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countriesEleana Bolla, Anne Grete Semb, Michelle Petri, et al.
Arthritis and Rheumatism|September 5, 2002
Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamideFrédéric A Houssiau, Carlos Vasconcelos, David D'Cruz, et al.
Pageof 33

Showing results (241-250 of 327) with videos related to

Sort By:
Pageof 33
International Journal of Rheumatic Diseases|May 23, 2022
Metabolic syndrome is associated with increased cardiovascular risk and disease damage in patients with Takayasu arteritisBurçin Sağlam, Sema Kaymaz-Tahra, Gökçe Kenar, et al.
BMC Medical Genomics|May 4, 2019
Structural variation of centromeric endogenous retroviruses in human populations and their impact on cutaneous T-cell lymphoma, Sézary syndrome, and HIV infectionMark H Kaplan, Mark Kaminski, Judith M Estes, et al.
Rheumatology (Oxford, England)|July 21, 2021
The assessment of presenteeism and activity impairment in Behçet's syndrome and recurrent aphthous stomatitis: a multicentre studyUmit Karacayli, Adebowale Adesanya, Aysun Aksoy, et al.
Infectious Diseases & Clinical Microbiology|April 18, 2024
Factors Associated with 28-day Critical Illness Development During the First Wave of COVID-19Uluhan Sili, Pınar Ay, Hüseyin Bilgin, et al.
Annals of the Rheumatic Diseases|January 24, 2018
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practiceChristian Dejaco, Sofia Ramiro, Christina Duftner, et al.
Seminars in Arthritis and Rheumatism|October 27, 2021
Biologic treatments in Takayasu's Arteritis: A comparative study of tumor necrosis factor inhibitors and tocilizumabFatma Alibaz-Oner, Sema Kaymaz-Tahra, Özün Bayındır, et al.
International Journal of Rheumatic Diseases|June 8, 2026
Outcomes of Vascular Interventions in Takayasu Arteritis and the Role of Biologic Therapy: A Multicenter Retrospective StudyAysegul Avcu, Sema Kaymaz-Tahra, Rıza Can Kardas, et al.
Arthritis and Rheumatism|December 14, 2004
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis TrialFrédéric A Houssiau, Carlos Vasconcelos, David D'Cruz, et al.
The Lancet. Rheumatology|November 22, 2025
Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countriesEleana Bolla, Anne Grete Semb, Michelle Petri, et al.
Arthritis and Rheumatism|September 5, 2002
Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamideFrédéric A Houssiau, Carlos Vasconcelos, David D'Cruz, et al.
Pageof 33